Merck & Company Inc (MRK)

95.30
-2.10(-2.16%)
  • Volume:
    300
  • Bid/Ask:
    95.30/95.40
  • Day's Range:
    95.30 - 96.40

MRK Overview

Prev. Close
97.4
Day's Range
95.3-96.4
Revenue
59.28B
Open
96.3
52 wk Range
72.61-108.8
EPS
5.73
Volume
300
Market Cap
244.25B
Dividend (Yield)
2.92
(2.73%)
Average Vol. (3m)
509
P/E Ratio
18.15
Beta
0.372
1-Year Change
35.41%
Shares Outstanding
2,538,592,467
Next Earnings Date
Apr 27, 2023
What is your sentiment on Merck&Co?
or
Market is currently closed. Voting is open during market hours.

Merck & Company Inc Company Profile

Merck & Company Inc Company Profile

Employees
67500
  • Type:Equity
  • Market:Germany
  • ISIN:US58933Y1055
  • WKN:A0YD8Q

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Read More

Analyst Price Target

Average120.81 (+15.95% Upside)
High155.00
Low96.00
Price104.19
No. of Analysts28
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy
  • Bearish
    0
    • And why keep it for dividend when uou can get 4-5 percent risk free
      0
      • This is hoing down to 80is within months!! Way overpriced and all other smaller players are beating them on new development
        0
        • hmm I just got in and naturally it will never see green again brutal
          0
          • Ignore small day to day changes. Long term is key.
            0
            • 120 loadin
              0
              • At this point a small adjustment is logical.
                0
                • Aehr test systems up the moon
                  0
                  • Good company, but the price is way too high in light of its growth prospect and economic condition.
                    1
                    • Breaking out . Watch for $120 Silvia,those dang "mrons and thier baseless predictions"
                      1
                      • why would anyone be buying at this inflated level. This has run its course.
                        1